10h
Stocktwits on MSNCassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains HopefulShares of Texas-based biotechnology company Cassava Sciences, Inc. (SAVA) tumbled 33% on Tuesday after the company reported ...
We are disappointed that the results of REFOCUS-ALZ and RETHINK-ALZ showed no treatment benefit for patients with mild-to-moderate Alzheimer’s ...
The Canucks and the Islanders are borderline playoff teams thanks to their head coaches Rick Tocchet and Patrick Roy.
Cassava Sciences has officially ended development of simufilam in Alzheimer’s disease, marking the end of a tumultuous era ...
Cassava Sciences has given up on simufilam in Alzheimer’s disease. | Cassava Sciences has given up on simufilam in ...
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with ...
Cassava Sciences said on Tuesday its Alzheimer's drug simufilam, which has been at the center of regulatory scrutiny, failed ...
2d
Card Chronicle on MSNThe Cardinals: Who’s Got Next?Been rereading what I along with many others consider among the best primers on the process of writing. Anne Lamott’s “Bird ...
The university officially announced on Friday the hiring of former Maryland AD Damon Evans, who will be replacing Rick Hart ...
The move comes amid the men’s basketball team opening play in the NCAA tournament and the women’s team set to host a ...
Thursday's first full NCAA Tournament day wasn't the most entertaining, but there are always plenty of intriguing happenings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results